Skip to main content

Phase 1b Study of PTC299 in Relapsed/Refractory Acute Leukemias

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

PTC Therapeutics, Inc

Start Date

January 7, 2020

End Date

January 14, 2025
 

Administered By

Duke Cancer Institute

Awarded By

PTC Therapeutics, Inc

Start Date

January 7, 2020

End Date

January 14, 2025